About this trial
The purpose of the study is to evaluate if firefighter exposure to hazardous compounds will increase the incidence of premalignant hematological states which subsequently increases the risk of the development of hematologic malignancies, and potentially other pathophysiological consequences.
Eligibility criteria
Qualifiers
Written informed consent and HIPAA authorization for release of personal health information.
Age ≥ 40-49 years at the time of consent (self-reported)
Ability of the participant to understand and comply with study procedures for the entire length of the study
Currently employed by Charlotte Fire Department (CFD) with at least 5 years on-the -job experience (self-reported)
Disqualifiers
None
Trial design
Treatments tested in this trial
- Monoclonal Gammopathy
- Complete Blood Count with differential (CBC w/ diff)
- Clonal hematopoiesis (CHIP)
Treatment groups
Sponsors and collaborators
Wake Forest University Health Sciences
Lead sponsor
Atrium Health Levine Cancer Institute
Collaborator